Dermatofibrosis Lenticularis (Buschke-Ollendorf Syndrome) Treatment & Management

1. Benli IT, Akalin S, Boysan E, Mumcu EF, Kis M, Türkoglu D. Epidemiological, clinical and radiological aspects of osteopoikilosis. J Bone Joint Surg Br. 1992 Jul. 74(4):504-6. [Medline].

2. Crivellato E. Disseminated nevus anelasticus. Int J Dermatol. 1986 Apr. 25(3):171-3. [Medline].

3. Dahan S, Bonafe JL, Laroche M, et al. [Iconography of Buschke Ollendorff syndrome: x ray computed tomography and nuclear magnetic resonance of osteopoikilosis]. Ann Dermatol Venereol. 1989. 116(3):225-30. [Medline].

4. Lin F, Morrison JM, Wu W, Worman HJ. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. Hum Mol Genet. 2005 Feb 1. 14(3):437-45. [Medline].

5. de la Salmonière P, Janier M, Chemlal K, Lazareth I, Carlotti A, Charasson I, et al. [Buschke-Ollendorff syndrome]. Ann Dermatol Venereol. 1994. 121(10):718-20. [Medline].

6. Umaretiya PJ, Miest RY, Tollefson MM. A 5-year-old with connective tissue nevi: Buschke-Ollendorff syndrome. J Pediatr. 2014 Jul. 165(1):206. [Medline].

7. Boyaci A, Boyaci N, Tutoglu A. Familial osteopoikilosis. J Back Musculoskelet Rehabil. 2013. 26(3):247-50. [Medline].

8. Giro MG, Duvic M, Smith LT, Kennedy R, Rapini R, Arnett FC, et al. Buschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture. J Invest Dermatol. 1992 Aug. 99(2):129-37. [Medline].

9. Ehrig T, Cockerell CJ. Buschke-Ollendorff syndrome: report of a case and interpretation of the clinical phenotype as a type 2 segmental manifestation of an autosomal dominant skin disease. J Am Acad Dermatol. 2003 Dec. 49(6):1163-6. [Medline].

10. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet. 2004 Nov. 36(11):1213-8. [Medline].

11. Trattner A, David M, Rothem A, Ben-David E, Sandbank M. Buschke-Ollendorff syndrome of the scalp: histologic and ultrastructural findings. J Am Acad Dermatol. 1991 May. 24(5 Pt 2):822-4. [Medline].

12. Ben-Asher E, Zelzer E, Lancet D. LEMD3: the gene responsible for bone density disorders (osteopoikilosis). Isr Med Assoc J. 2005 Apr. 7(4):273-4. [Medline].

13. Grimer RJ, Davies AM, Starkie CM, Sneath RS. [Chondrosarcoma in a patient with osteopoikilosis. Apropos of a case]. Rev Chir Orthop Reparatrice Appar Mot. 1989. 75(3):188-90. [Medline].

14. Lagier R, Mbakop A, Bigler A. Osteopoikilosis: a radiological and pathological study. Skeletal Radiol. 1984. 11(3):161-8. [Medline].

15. Saussine A, Marrou K, Delanoé P, et al. Connective tissue nevi: An entity revisited. J Am Acad Dermatol. 2011 Oct 18. [Medline].

16. Pope V, Dupuis L, Kannu P, Mendoza-Londono R, Sajic D, So J, et al. Buschke-Ollendorff syndrome: a novel case series and systematic review. Br J Dermatol. 2016 Apr. 174 (4):723-9. [Medline].

17. Blum AE, Hatter A, Honda K, Lu K. An unusual presentation of Buschke-Ollendorff syndrome. J Am Acad Dermatol. 2011 Jul. 65(1):e25-6. [Medline].

18. Ayling RM, Evans PE. Giant cell tumor in a patient with osteopoikilosis. Acta Orthop Scand. 1988 Feb. 59(1):74-6. [Medline].

19. Morrison JG, Jones EW, MacDonald DM. Juvenile elastoma and osteopoikilosis (the Buschke--Ollendorff syndrome). Br J Dermatol. 1977 Oct. 97(4):417-22. [Medline].

20. Schorr WF, Optiz JM, Reyes CN. The connective tissue nevus-osteopoikilosis syndrome. Arch Dermatol. 1972 Aug. 106(2):208-14. [Medline].

21. Gracia-Cazaña T, Frias M, Roselló R, Vera-Álvarez J, Gilaberte Y. PASH syndrome associated with osteopoikilosis. Int J Dermatol. 2015 Sep. 54 (9):e369-71. [Medline].

22. Al Attia HM, Sherif AM. Buschke-Ollendorff syndrome in a grande multipara: a case report and short review of the literature. Clin Rheumatol. 1998. 17(2):172-5. [Medline].

23. Atherton DJ, Wells RS. Juvenile elastoma and osteopoikilosis (the Buschke-Ollendorf syndrome). Clin Exp Dermatol. 1982 Jan. 7(1):109-13. [Medline].

24. Cantatore FP, Carrozzo M, Loperfido MC. Mixed sclerosing bone dystrophy with features resembling osteopoikilosis and osteopathia striata. Clin Rheumatol. 1991 Jun. 10(2):191-5. [Medline].

25. Miklaszewska M, Szybejko-Machaj G, Szepietowski J. [Buschke-Ollendorf syndrome - case report with a literature review.]. Dermatol Klin Zabieg. 1999. 2:85-9.

26. Schnur RE, Grace K, Herzberg A. Buschke-Ollendorff syndrome, otosclerosis, and congenital spinal stenosis. Pediatr Dermatol. 1994 Mar. 11(1):31-4. [Medline].

27. Woodrow SL, Pope FM, Handfield-Jones SE. The Buschke-Ollendorff syndrome presenting as familial elastic tissue naevi. Br J Dermatol. 2001 Apr. 144(4):890-3. [Medline].

28. Surrenti T, Callea F, De Horatio LT, Diociaiuti A, El Hachem M. Buschke-Ollendorff syndrome: sparing unnecessary investigations. Cutis. 2014 Aug. 94(2):97-100. [Medline].

29. Cañueto J, Román C, Santos-Briz Á, Ciria S, González R, Unamuno P. Papular elastorrhexis and Buschke-Ollendorff syndrome are different entities. J Am Acad Dermatol. 2011 Jul. 65 (1):e7-9. [Medline].

30. Kennedy JG, Donahue JR, Aydin H, Hoang BH, Huvos A, Morris C. Metastatic breast carcinoma to bone disguised by osteopoikilosis. Skeletal Radiol. 2003 Apr. 32(4):240-3. [Medline].

31. Holbrook KA, Byers PH. Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders. J Invest Dermatol. 1982 Jul. 79 Suppl 1:7s-16s. [Medline].

Vernon J Forrester, MD Resident Physician, Department of Dermatology, UVA Health System, University of Virginia School of Medicine

Disclosure: Nothing to disclose.

Krista Roncone University of Virginia School of Medicine

Disclosure: Nothing to disclose.

Barbara B Wilson, MD Edward P Cawley Associate Professor, Department of Dermatology, University of Virginia School of Medicine

Barbara B Wilson, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Medical Society of Virginia, Sigma Xi

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Society for MOHS Surgery, Association of Military Dermatologists, Phi Beta Kappa

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Jacek C Szepietowski, MD, PhD Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland

Disclosure: Received consulting fee from Orfagen for consulting; Received consulting fee from Maruho for consulting; Received consulting fee from Astellas for consulting; Received consulting fee from Abbott for consulting; Received consulting fee from Leo Pharma for consulting; Received consulting fee from Biogenoma for consulting; Received honoraria from Janssen for speaking and teaching; Received honoraria from Medac for speaking and teaching; Received consulting fee from Dignity Sciences for consulting; .

Grazyna Szybejko-Machaj, MD, PhD Assistant Professor, Department of Dermatology, Wroclaw Medical University

Disclosure: Nothing to disclose.

Lukasz Matusiak, MD, PhD Assistant, Department and Clinic of Dermatology, Venereology and Allergology, Medical University of Wroclaw

Disclosure: Nothing to disclose.

Mark A Crowe, MD Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine

Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society

Disclosure: Nothing to disclose.

Mieczyslawa Miklaszewska, MD, PhD Professor, Department of Dermatology, Medical University in Wroclaw, Poland

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article